Valenti, M., Ibba, L., Giulio, S. D., Gargiulo, L., Malagoli, P., Balato, A., . . . Narcisi, A. Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis). Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationValenti, Mario, et al. Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 Mg and 200 Mg—IL PSO (Italian Landscape Psoriasis). Adis, Springer Healthcare.
MLA (9th ed.) CitationValenti, Mario, et al. Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 Mg and 200 Mg—IL PSO (Italian Landscape Psoriasis). Adis, Springer Healthcare.
Warning: These citations may not always be 100% accurate.